|
UW Comprehensive Cancer Center Support
|
3P30CA014520-36S1
|
$59,955
|
$2,398
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-36
|
$4,736,061
|
$189,442
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Tumor Cell Biology Training Program
|
5T32CA009361-29
|
$704,512
|
$140,902
|
STILES, CHARLES
|
DANA-FARBER CANCER INSTITUTE
|
|
The Synergy Between Radiotherapy and Molecularly Targeted Agents
|
ZIA SC 010373
|
$1,055,348
|
$158,302
|
Camphausen, Kevin
|
CCR (NCI)
|
|
The Role of Merlin Phosphorylation on its Tumor Suppressive Activity
|
5R01CA117872-04
|
$207,330
|
$207,330
|
YE, KEQIANG
|
EMORY UNIVERSITY
|
|
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression
|
ZIA BC 010015
|
$284,185
|
$56,837
|
Wang, Ji Ming
|
CCR (NCI)
|
|
Telomerase in Development, Senescence and Neoplasia
|
5R01CA084628-17
|
$595,470
|
$148,868
|
DePinho, Ronald
|
DANA-FARBER CANCER INSTITUTE
|
|
Targeting Tumor Angiogenesis with G-Quadruplex Binders
|
3R01CA109069-04S1
|
$53,213
|
$26,607
|
SUN, DAEKYU
|
UNIVERSITY OF ARIZONA
|
|
Targeting Tumor Angiogenesis with G-Quadruplex Binders
|
5R01CA109069-04
|
$260,253
|
$130,127
|
SUN, DAEKYU
|
UNIVERSITY OF ARIZONA
|
|
Targeting High-risk Neuroblastoma using high through put siRNA screening
|
ZIA BC 010806
|
$95,643
|
$28,693
|
Khan, Javed
|
CCR (NCI)
|
|
Symptom Cluster Subgroups in Adult Survivors of Childhood Cancers
|
1R01CA136912-01A2
|
$239,033
|
$23,903
|
Finnegan, Lorna
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Statistical Methods for Analysis of Failure Time Data
|
5R01CA075971-11
|
$234,874
|
$58,719
|
Betensky, Rebecca
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
|
Statistical Inference on Chemotherapy Effects from Flow Cytometry Data
|
5R01CA134839-02
|
$234,465
|
$117,233
|
Hyrien, Ollivier
|
UNIVERSITY OF ROCHESTER
|
|
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
|
ZIA BC 010958
|
$437,219
|
$21,861
|
Daar, Ira
|
CCR (NCI)
|
|
ROLE OF NONCANONICAL WNT PATHWAYS IN TISSUE MORPHOGENESIS.
|
ZIA BC 010841
|
$150,805
|
$150,805
|
Yamaguchi, Terry
|
CCR (NCI)
|
|
Role of Neurotrophins in the Development of the Mammalian Nervous System
|
ZIA BC 010390
|
$428,531
|
$21,427
|
Tessarollo, Lino
|
CCR (NCI)
|
|
RNA interference approach to dissect roles of notochord regulators
|
ZIA BC 011121
|
$92,179
|
$27,654
|
Mackem, Susan
|
CCR (NCI)
|
|
Research Training in Neuro-Oncology
|
5T32CA009574-22
|
$188,913
|
$47,228
|
GROSSMAN, STUART
|
JOHNS HOPKINS UNIVERSITY
|
|
Research Management and Support
|
RMS2009 [E]
|
$350,982,837
|
$137,000
|
N/A
|
National Cancer Institute
|
|
Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma
|
ZIA BC 010788
|
$515,188
|
$103,038
|
Thiele-Galetto, Carol
|
CCR (NCI)
|
|
Regulation of Apoptosis in Ewing's Sarcoma and Neuroblastoma
|
ZIA SC 010058
|
$326,295
|
$32,629
|
Tsokos, Maria
|
CCR (NCI)
|
|
Radiation Therapy Oncology Group
|
2U10CA021661-33
|
$12,534,580
|
$376,037
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Protein Structure, Stability, and Amyloid Formation
|
ZIA BC 010440
|
$480,077
|
$33,605
|
Nussinov, Ruth
|
CCR (NCI)
|
|
Postmortem Pathology
|
ZIC BC 010685
|
$438,710
|
$21,935
|
Kleiner, David
|
CCR (NCI)
|
|
Phase II Trial of O6-Benzylguanine and Temozolomide in Pediatric Patients with Hi
|
ZIA BC 010590
|
$24,404
|
$3,661
|
Warren, Katherine
|
CCR (NCI)
|
|
Phase II Topic 233: Automated Processing of Cancer-Related Data
|
N44CO900040-000
|
$749,996
|
$374,998
|
March, Suzanne
|
QUANTUMMARK LLC:1133028
|
|
PD GWAS Consortium
|
1R01CA141668-01
|
$399,998
|
$399,998
|
FOROUD, Tatiana
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma
|
ZIA BC 010789
|
$515,188
|
$51,519
|
Thiele-Galetto, Carol
|
CCR (NCI)
|
|
Oligosaccharide Substrate and Inhibitor Interactions with beta-1,4-Gal-T1
|
ZIA BC 010041
|
$37,409
|
$748
|
Qasba, Pradman
|
CCR (NCI)
|
|
Neurorestorative Strategy for Chemotherapy-induced Peripheral Neuropathy
|
1R43CA141819-01
|
$326,711
|
$326,711
|
LI, FENG-QIAO
|
COGNOSCI, INC.
|
|
NanoBioSensor Initiative
|
ZIA BC 011036
|
$95,643
|
$4,782
|
Khan, Javed
|
CCR (NCI)
|
|
Mouse models for pRB growth control via E2F/DP action
|
5R01CA079646-10
|
$341,522
|
$170,761
|
Yamasaki, Lili
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIA BC 011038
|
$1,027,647
|
$51,382
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Targeting of Developmental Cancers in Children
|
5P01CA106450-05
|
$2,575,193
|
$643,798
|
O'REILLY, RICHARD
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Molecular Mechanisms of Proliferation and Infiltration of Astrocytoma
|
ZIA BC 010540
|
$295,659
|
$103,481
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Molecular Mechanisms of Drugs
|
ZIA BC 010594
|
$191,287
|
$38,257
|
Khan, Javed
|
CCR (NCI)
|
|
Modeling of amyloid peptides and proteins
|
ZIA BC 010722
|
$321,435
|
$160,717
|
Guy, H. Robert
|
CCR (NCI)
|
|
Micro RNA Profiling in Pediatric Cancers
|
ZIA BC 011001
|
$95,643
|
$4,782
|
Khan, Javed
|
CCR (NCI)
|
|
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
|
ZIA BC 010006
|
$437,219
|
$43,722
|
Daar, Ira
|
CCR (NCI)
|
|
Mechanisms of ATM activation
|
1R01CA132813-01A1
|
$250,454
|
$250,454
|
PAULL, TANYA
|
UNIVERSITY OF TEXAS AUSTIN
|
|
Isolation of genes for radiation sensitivity
|
5R01CA057569-18
|
$299,141
|
$299,141
|
Concannon, Patrick
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-11S1
|
$113,669
|
$4,547
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-11S2
|
$49,258
|
$1,970
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
5P30CA082709-11
|
$1,302,544
|
$52,102
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
IL-2/IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
|
ZIA SC 004002
|
$1,316,844
|
$105,348
|
Waldmann, Thomas
|
CCR (NCI)
|
|
Identification of Novel Protein Phosphatases in the ATM Signaling Pathway
|
1R03CA142605-01
|
$69,768
|
$17,442
|
LU, XIONGBIN
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$726,889
|
$36,344
|
Khan, Javed
|
CCR (NCI)
|
|
Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma
|
ZIA BC 010539
|
$591,319
|
$59,132
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Identification of Genes for Predicting Prognosis in Pediatric Cancers
|
ZIA SC 010366
|
$95,643
|
$19,129
|
Khan, Javed
|
CCR (NCI)
|
|
Huntington Interacting Protein-1(HIP1) and the Promotion of Neoplasia
|
5R01CA098730-06
|
$265,965
|
$265,965
|
ROSS, THEODORA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
Total relevant funding to Central Nervous System - Not Including Brain for this search: $8,840,801
|